A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Condition:   Poliomyelitis Interventions:   Biological: vaccination with novel OPV2 candidate 1 vaccine;   Biological: vaccination with novel OPV2 candidate 2 vaccine;   Biological: Placebo (Sirupus simplex, Propylenglycolum,. European Pharmacopoeia (Ph.Eur.)) Sponsors:   Pierre Van Damme;   Bill and Melinda Gates Foundation;   Centers for Disease Control and Prevention;   PATH;   Celerion Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials